Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) Institutional Ownership
CUSIP: 92511W207
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
49
Shares (Excl. Options)
5,196,096
Price
$8.31
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Symbol
- VRCA on Nasdaq
- Shares outstanding
- 8,810,762
- Price per share
- $6.26
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 5,196,096
- Total reported value
- $43,155,907
- % of total 13F portfolios
- 0%
- Share change
- +2,491,386
- Value change
- +$20,755,741
- Number of holders
- 49
- Price from insider filings
- $6.26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value is tracked under CUSIP 92511W207.
- 49 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 31 to 49 between Q3 2025 and Q4 2025.
- Reported value moved from $10,583,119 to $43,155,907.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 92511W207?
CUSIP 92511W207 identifies VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 92511W207:
Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Manning Paul B | 50% | $28,437,789 | 8,056,031 | Paul B Manning | 25 Nov 2025 | |||
| Caligan Partners LP | 10% | 0% | $43,635,492 | 6,503,054 | 0% | Caligan Partners LP | 26 Dec 2025 | |
| Affinity Asset Advisors, LLC | 5.5% | +0.6% | $7,346,762 | 884,172 | 0% | Affinity Asset Advisors, LLC | 22 Jan 2026 | |
| ARMISTICE CAPITAL, LLC | 5% | -25% | $3,649,153 | -$1,656,149 | 439,657 | -31% | Armistice Capital, LLC | 31 Dec 2025 |
As of 31 Dec 2025, 49 institutional investors reported holding 5,196,096 shares of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA). This represents 59% of the company’s total 8,810,762 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 13% | 1,118,925 | +75% | 0.23% | $9,298,267 |
| Caligan Partners LP | 10% | 923,910 | 0% | 0.7% | $7,677,692 |
| Affinity Asset Advisors, LLC | 8% | 707,338 | 0.42% | $5,877,979 | |
| Velan Capital Investment Management LP | 5.4% | 471,559 | 2.3% | $3,918,655 | |
| Stonepine Capital Management, LLC | 4% | 353,669 | 2.3% | $2,938,989 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 3.2% | 280,734 | 0% | 0.06% | $2,332,900 |
| Kalehua Capital Management LLC | 2.7% | 235,779 | 0% | 2% | $1,959,323 |
| DAFNA Capital Management LLC | 2% | 173,451 | 0.33% | $1,441,378 | |
| VANGUARD GROUP INC | 1.6% | 138,194 | -39% | 0% | $1,148,392 |
| TWO SIGMA INVESTMENTS, LP | 1.3% | 118,218 | 0% | $982,392 | |
| JANE STREET GROUP, LLC | 1.2% | 101,722 | 0% | $845,310 | |
| MARSHALL WACE, LLP | 0.97% | 85,173 | 0% | $707,786 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.77% | 67,659 | 0% | 0% | $562,388 |
| TWO SIGMA ADVISERS, LP | 0.5% | 44,430 | 0% | $369,213 | |
| Squarepoint Ops LLC | 0.38% | 33,270 | 0% | $276,474 | |
| Sovran Advisors, LLC | 0.37% | 32,658 | -56% | 0.02% | $248,527 |
| RENAISSANCE TECHNOLOGIES LLC | 0.3% | 26,400 | -9.6% | 0% | $219,384 |
| Mariner, LLC | 0.28% | 24,544 | -0.02% | 0% | $203,961 |
| STATE STREET CORP | 0.27% | 23,481 | +14% | 0% | $195,127 |
| MILLENNIUM MANAGEMENT LLC | 0.26% | 23,123 | -68% | 0% | $192,152 |
| OMERS ADMINISTRATION Corp | 0.26% | 22,600 | 0% | $187,806 | |
| MORGAN STANLEY | 0.25% | 22,009 | +1.5% | 0% | $182,894 |
| NORTHERN TRUST CORP | 0.23% | 20,024 | -0.03% | 0% | $166,400 |
| GOLDMAN SACHS GROUP INC | 0.21% | 18,621 | 0% | $154,741 | |
| HRT FINANCIAL LP | 0.2% | 17,356 | 0% | $144,000 |